General anesthetics inhibit erythropoietin induction under hypoxic conditions in the mouse brain

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Tanaka, Tomoharu ^a   Kai, Shinichi ^a   Koyama, Tomohiro ^a   Daijo, Hiroki ^a   Adachi, Takehiko ^b   Fukuda, Kazuhiko ^a   Hirota, Kiichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b Kitano Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HALOTHANE; HYPOXIA INDUCIBLE FACTOR 2ALPHA; ISOFLURANE; KETAMINE; MESSENGER RNA; NITROUS OXIDE; PHENOBARBITAL; PROPOFOL; SEVOFLURANE; ANESTHETIC AGENT;

ANESTHESIA MECHANISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; GENE; GENE EXPRESSION; GENE TARGETING; GENERAL ANESTHESIA; HEMODYNAMICS; HIF GENE; IMMUNOBLOTTING; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; ANOXIA; BAGG ALBINO MOUSE; BIOSYNTHESIS; BRAIN; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; GENETICS; METABOLISM;

ANESTHETICS, GENERAL; ANIMALS; ANOXIA; BRAIN; CELLS, CULTURED; ERYTHROPOIETIN; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; UP-REGULATION;

EID: 84455192443     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029378     Document Type: Article

References (72)

1. Selim M, (2007) Perioperative stroke. N Engl J Med 356: 706-713.
2. Ginsberg MD, (2009) Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 40: S111-114.
3. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, et al. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8: 495-505.
4. Sanchez PE, Fares RP, Risso JJ, Bonnet C, Bouvard S, et al. (2009) Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons. Proc Natl Acad Sci U S A 106: 9848-9853.
5. Brines M, Cerami A, (2005) Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6: 484-494.
6. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, et al. (1994) A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269: 19488-19493.
7. Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, et al. (1996) Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 8: 666-676.
8. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, et al. (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19: 643-651.
9. Marti HH, (2004) Erythropoietin and the hypoxic brain. J Exp Biol 207: 3233-3242.
10. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, et al. (2002) Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22: 10291-10301.
11. Kim I, Kim CH, Yim YS, Ahn YS, (2008) Autocrine function of erythropoietin in IGF-1-induced erythropoietin biosynthesis. Neuroreport 19: 1699-1703.
12. Noguchi CT, Asavaritikrai P, Teng R, Jia Y, (2007) Role of erythropoietin in the brain. Crit Rev Oncol Hematol 64: 159-171.
13. Sirén AL, Knerlich F, Poser W, Gleiter CH, Brück W, et al. (2001) Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol 101: 271-276.
14. Yamasaki M, Mishima HK, Yamashita H, Kashiwagi K, Murata K, et al. (2005) Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res 1050: 15-26.
15. Chen G, Shi J, Hang CH, Xie W, Liu J, et al. (2007) Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci Lett 425: 177-182.
16. Stockmann C, Fandrey J, (2006) Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression. Clin Exp Pharmacol Physiol 33: 968-979.
17. Wang GL, Semenza GL, (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 90: 4304-4308.
18. Hirota K, (2002) Hypoxia-inducible factor 1, a master transcription factor of cellular hypoxic gene expression. J Anesth 16: 150-159.
19. Wang GL, Jiang BH, Rue EA, Semenza GL, (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92: 5510-5514.
20. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL, (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271: 17771-17778.
21. Hirota K, Semenza GL, (2005) Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases. Biochem Biophys Res Commun 338: 610-616.
22. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, et al. (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci U S A 94: 4273-4278.
23. Holmquist-Mengelbier L, Fredlund E, Löfstedt T, Noguera R, Navarro S, et al. (2006) Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10: 413-423.
24. Hu CJ, Iyer S, Sataur A, Covello KL, Chodosh LA, et al. (2006) Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells. Mol Cell Biol 26: 3514-3526.
25. Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, et al. (2007) Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117: 1068-1077.
26. Itoh T, Namba T, Fukuda K, Semenza GL, Hirota K, (2001) Reversible inhibition of hypoxia-inducible factor 1 activation by exposure of hypoxic cells to the volatile anesthetic halothane. FEBS Lett 509: 225-229.
27. Li QF, Wang XR, Yang YW, Su DS, (2006) Up-regulation of hypoxia inducible factor 1alpha by isoflurane in Hep3B cells. Anesthesiology 105: 1211-1219.
28. Li QF, Zhu YS, Jiang H, (2008) Isoflurane preconditioning activates HIF-1alpha, iNOS and Erk1/2 and protects against oxygen-glucose deprivation neuronal injury. Brain Res 1245: 26-35.
29. Raphael J, Zuo Z, Abedat S, Beeri R, Gozal Y, (2008) Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin. Anesthesiology 108: 415-425.
30. Arcasoy MO, (2008) The non-haematopoietic biological effects of erythropoietin. Br J Haematol 141: 14-31.
31. Hieber S, Huhn R, Hollmann MW, Weber NC, Preckel B, (2009) Hypoxia-inducible factor 1 and related gene products in anaesthetic-induced preconditioning. Eur J Anaesthesiol 26: 201-206.
32. Chavez JC, Baranova O, Lin J, Pichiule P, (2006) The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26: 9471-9481.
33. McAuliffe JJ, Loepke AW, Miles L, Joseph B, Hughes E, et al. (2009) Desflurane, isoflurane, and sevoflurane provide limited neuroprotection against neonatal hypoxia-ischemia in a delayed preconditioning paradigm. Anesthesiology 111: 533-546.
34. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE, (1991) Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci U S A 88: 5680-5684.
35. Hu CJ, Sataur A, Wang L, Chen H, Simon MC, (2007) The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell 18: 4528-4542.
36. Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, et al. (2005) Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 25: 5675-5686.
37. Michenfelder JD, Sundt TM Jr, (1973) The effect of Pa CO2 on the metabolism of ischemic brain in squirrel monkeys. Anesthesiology 38: 445-453.
38. Weidemann A, Johnson RS, (2009) Nonrenal regulation of EPO synthesis. Kidney Int 75: 682-688.
39. Yu X, Lin CS, Costantini F, Noguchi CT, (2001) The human erythropoietin receptor gene rescues erythropoiesis and developmental defects in the erythropoietin receptor null mouse. Blood 98: 475-477.
40. Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, et al. (2002) Erythropoietin receptor signalling is required for normal brain development. Development 129: 505-516.
41. Tsai PT, Ohab JJ, Kertesz N, Groszer M, Matter C, et al. (2006) A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci 26: 1269-1274.
42. Sofroniew MV, Vinters HV, (2010) Astrocytes: biology and pathology. Acta Neuropathol 119: 7-35.
43. Fink BR, Haschke RH, (1973) Anesthetic effects on cerebral metabolism. Anesthesiology 39: 199-215.
44. Tanaka T, Wakamatsu T, Daijo H, Oda S, Kai S, et al. (2010) Persisting mild hypothermia suppresses hypoxia-inducible factor-1alpha protein synthesis and hypoxia-inducible factor-1-mediated gene expression. Am J Physiol Regul Integr Comp Physiol 298: R661-671.
45. Kress HG, (1997) [Mechanisms of action of ketamine]. Anaesthesist 46 (Suppl 1): S8-19.
46. Sato Y, Kobayashi E, Murayama T, Mishina M, Seo N, (2005) Effect of N-methyl-D-aspartate receptor epsilon1 subunit gene disruption of the action of general anesthetic drugs in mice. Anesthesiology 102: 557-561.
47. Franks NP, Lieb WR, (1994) Molecular and cellular mechanisms of general anaesthesia. Nature 367: 607-614.
48. Davies PA, Hanna MC, Hales TG, Kirkness EF, (1997) Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit. Nature 385: 820-823.
49. Miyazaki H, Nakamura Y, Arai T, Kataoka K, (1997) Increase of glutamate uptake in astrocytes: a possible mechanism of action of volatile anesthetics. Anesthesiology 86: 1359-1366; discussion 1358A.
50. Hemmings HJ, (1998) General anesthetic effects on protein kinase C. Toxicol Lett 100-101: 89-95.
51. Itoh T, Hirota K, Hisano T, Namba T, Fukuda K, (2004) The volatile anesthetics halothane and isoflurane differentially modulate proinflammatory cytokine-induced p38 mitogen-activated protein kinase activation. J Anesth 18: 203-209.
52. Kevin LG, Novalija E, Stowe DF, (2005) Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg 101: 1275-1287.
53. Taylor CT, (2008) Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J 409: 19-26.
54. Hui AS, Bauer AL, Striet JB, Schnell PO, Czyzyk-Krzeska MF, (2006) Calcium signaling stimulates translation of HIF-alpha during hypoxia. FASEB J 20: 466-475.
55. Richard DE, Berra E, Gothié E, Roux D, Pouysségur J, (1999) p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 274: 32631-32637.
56. Ke Q, Costa M, (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70: 1469-1480.
57. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, et al. (2001) HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15: 2445-2453.
58. Gu GJ, Li YP, Peng ZY, Xu JJ, Kang ZM, et al. (2008) Mechanism of ischemic tolerance induced by hyperbaric oxygen preconditioning involves upregulation of hypoxia-inducible factor-1alpha and erythropoietin in rats. J Appl Physiol 104: 1185-1191.
59. Yeo EJ, Cho YS, Kim MS, Park JW, (2008) Contribution of HIF-1alpha or HIF-2alpha to erythropoietin expression: in vivo evidence based on chromatin immunoprecipitation. Ann Hematol 87: 11-17.
60. Ntaios G, Savopoulos C, Chatzinikolaou A, Hatzitolios A, (2008) The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside. Acta Neurol Scand 118: 362-366.
61. Zhu C, Kang W, Xu F, Cheng X, Zhang Z, et al. (2009) Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 124: e218-226.
62. Tseng MY, Hutchinson PJ, Richards HK, Czosnyka M, Pickard JD, et al. (2009) Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article. J Neurosurg 111: 171-180.
63. Rappaport B, Mellon RD, Simone A, Woodcock J, (2011) Defining safe use of anesthesia in children. N Engl J Med 364: 1387-1390.
64. Mellon RD, Simone AF, Rappaport BA, (2007) Use of anesthetic agents in neonates and young children. Anesth Analg 104: 509-520.
65. Patel P, Sun L, (2009) Update on neonatal anesthetic neurotoxicity: insight into molecular mechanisms and relevance to humans. Anesthesiology 110: 703-708.
66. Cattano D, Williamson P, Fukui K, Avidan M, Evers A, et al. (2008) Potential of xenon to induce or to protect against neuroapoptosis in the developing mouse brain. Can J Anaesth 55: 429-436.
67. El Hasnaoui-Saadani R, Pichon A, Marchant D, Olivier P, Launay T, et al. (2009) Cerebral adaptations to chronic anemia in a model of erythropoietin-deficient mice exposed to hypoxia. Am J Physiol Regul Integr Comp Physiol 296: R801-811.
68. Nishi K, Oda T, Takabuchi S, Oda S, Fukuda K, et al. (2008) LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. Antioxid Redox Signal 10: 983-995.
69. Toda Y, Kono K, Abiru H, Kokuryo K, Endo M, et al. (1999) Application of tyramide signal amplification system to immunohistochemistry: a potent method to localize antigens that are not detectable by ordinary method. Pathol Int 49: 479-483.
70. Asou H, Hirano S, Kohsaka S, (1989) Changes in ganglioside composition and morphological features during the development of cultured astrocytes from rat brain. Neurosci Res 6: 369-375.
71. Calvert JW, Cahill J, Yamaguchi-Okada M, Zhang JH, (2006) Oxygen treatment after experimental hypoxia-ischemia in neonatal rats alters the expression of HIF-1alpha and its downstream target genes. J Appl Physiol 101: 853-865.
72. Takabuchi S, Hirota K, Nishi K, Oda S, Oda T, et al. (2004) The intravenous anesthetic propofol inhibits hypoxia-inducible factor 1 activity in an oxygen tension-dependent manner. FEBS Lett 577: 434-438.